Sort
10,766 grants matching “checkpoint inhibitor”
Target validation of CD206 activators
$43,643Anton Simeonov · National Center For Advancing Translational Sciences · ZIA · FY2019 · TR
Genotoxic effects of L1 retrotransposition trigger oocyte elimination during MPI
$43,576Marla Elizabeth Tharp · Johns Hopkins University · F31 · FY2016 · HD
Cleavage of Bcl-xL by Caspases contributes to cell death in vivo
$43,576Jason Huska · Johns Hopkins University · F31 · FY2016 · AI
Role of Acid in the Development of Barrett's Esophagus
$43,563Rhonda F Souza · Ut Southwestern Medical Center · R01 · FY2010 · DK
Regulation of transendothelial migration of Tregs in irradiated HNSCCs by EphB4-ephrinB2 interaction
$43,552Laurel B Darragh · University Of Colorado Denver · F31 · FY2022 · DE
Determining the spatial contexts that modulate immune cell phenotypes in colorectal cancer
$43,452Jeremy D'silva · Stanford University · F31 · FY2025 · CA
KLRG1 as a novel target for immune checkpoint blockade
$43,410Angela Tata · Brown University · F31 · FY2020 · CA
Gene and Virus Therapy Program
$43,374Mitesh Borad · Mayo Clinic Rochester · P30 · FY2022 · CA
The roles of AP-1 pathway activation in NK cell development and exhaustion programming in AML
$43,287Erin G. Jeremy · Ohio State University · F30 · FY2024 · CA
Improvement of cellular immunotherapy during dysbiosis - A. A. Brint Supplement
$43,275Ruud P.m. Dings · Univ Of Arkansas For Med Scis · R01 · FY2024 · CA
Gene and Virus Therapy Program
$43,250Mitesh Borad · Mayo Clinic Rochester · P30 · FY2023 · CA
Gene and Virus Therapy Program
$43,250Mitesh Borad · Mayo Clinic Rochester · P30 · FY2021 · CA
Assessing TGF Beta1-Mediated ECM Remodeling in Metastatic Oral Squamous Cell Carcinoma
$43,072John Aleman · University Of Colorado Denver · F31 · FY2022 · DE
The replication checkpoint and genomic fidelity in skin
$43,065University Of Washington · K02 · FY2005 · AR
FOXA1 loss-of-function induces inflammatory cytokine signaling and immune suppression in prostate cancer
$42,907Lourdes Brea · Northwestern University At Chicago · F31 · FY2023 · CA
Investigating mechanisms of pathogenesis and treatment response in immune checkpoint inhibitor induced colitis
$42,878Jacqueline Mann · Yale University · F32 · FY2024 · CA
Regulation of transendothelial migration of Tregs in irradiated HNSCCs by EphB4-ephrinB2 interaction
$42,836Laurel B Darragh · University Of Colorado Denver · F31 · FY2021 · DE
Program 30: Neuro-Oncology
$42,805Charles Stiles · Dana-Farber Cancer Inst · P30 · FY2017 · CA
Thymic PD-1 blockade mediates the anti-tumor immune response in pediatric high-grade glioma
$42,691Connor Patrick Francis · University Of Florida · F30 · FY2023 · CA
The use of epigenetic therapy to activate an immune response in ovarian cancer
$42,608Katherine B Chiappinelli · Johns Hopkins University · F32 · FY2015 · CA
Protection of kidney from autoimmunity by modulating co-stimlatory signaling
$42,390Naoka Murakami · Brigham And Women'S Hospital · K08 · FY2023 · DK
Targeting intracellular trafficking for cancer therapy
$42,358Brendan Tyler Finicle · University Of California-Irvine · F99 · FY2021 · CA
Design and Delivery of Neoantigen-based Tumor Vaccines
$42,157Christof Chiu Smith · Univ Of North Carolina Chapel Hill · F30 · FY2020 · CA
Program 12: Developmental Therapeutics
$42,116Geoffrey I Shapiro · Dana-Farber Cancer Inst · P30 · FY2023 · CA
Program 12: Developmental Therapeutics
$42,116Geoffrey I Shapiro · Dana-Farber Cancer Inst · P30 · FY2022 · CA